BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 28555082)

  • 21. Comparative genomic analysis of PML and RARA breakpoints in paired diagnosis/relapse samples of patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.
    Iaccarino L; Ottone T; Hasan SK; Divona M; Cicconi L; Lavorgna S; Alfonso V; Basso G; Barragán E; Bocchia M; Rego EM; Grimwade D; Voso MT; Lo-Coco F
    Leuk Lymphoma; 2018 May; 59(5):1268-1270. PubMed ID: 28838264
    [No Abstract]   [Full Text] [Related]  

  • 22. An ider(17)(q10)t(15;17) with spliced long-type PML-RARA fusion transcripts in a case of acute promyelocytic leukemia.
    Hu X; Ai G; Meng X; Hou J; Wei R; Tao Y; Zhang Q; Han Y; Shi J
    Cancer Genet; 2014 Jun; 207(6):253-7. PubMed ID: 25052141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular pathology of acute promyelocytic leukemia.
    Chang KS
    Hematol Pathol; 1993; 7(4):209-23. PubMed ID: 8113150
    [No Abstract]   [Full Text] [Related]  

  • 24. Identification of novel recurrent CPSF6-RARG fusions in acute myeloid leukemia resembling acute promyelocytic leukemia.
    Liu T; Wen L; Yuan H; Wang Y; Yao L; Xu Y; Cen J; Ruan C; Wu D; Chen S
    Blood; 2018 Apr; 131(16):1870-1873. PubMed ID: 29487068
    [No Abstract]   [Full Text] [Related]  

  • 25. A novel NUP98/RARG gene fusion in acute myeloid leukemia resembling acute promyelocytic leukemia.
    Such E; Cervera J; Valencia A; Barragán E; Ibañez M; Luna I; Fuster O; Perez-Sirvent ML; Senent L; Sempere A; Martinez J; Martín-Aragonés G; Sanz MA
    Blood; 2011 Jan; 117(1):242-5. PubMed ID: 20935257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Arsenic and retinoic acid, toward targeted treatments of acute promyelocytic anemia?].
    de Thé H
    C R Seances Soc Biol Fil; 1998; 192(2):273-81. PubMed ID: 9759370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PML-RARalpha ligand-binding domain deletion mutations associated with reduced disease control and outcome after first relapse of APL.
    Schachter-Tokarz E; Kelaidi C; Cassinat B; Chomienne C; Gardin C; Raffoux E; Dombret H; Fenaux P; Gallagher R
    Leukemia; 2010 Feb; 24(2):473-6. PubMed ID: 19865110
    [No Abstract]   [Full Text] [Related]  

  • 28. ider(17)(q10)t(15;17) associated with relapse and poor prognosis in a pediatric patient with acute promyelocytic leukemia.
    Kim MJ; Yoon HS; Cho SY; Lee HJ; Suh JT; Lee J; Yoon HJ; Lee WI; Park TS
    Cancer Genet Cytogenet; 2010 Sep; 201(2):116-21. PubMed ID: 20682396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a novel CPSF6-RARG fusion transcript in acute myeloid leukemia resembling acute promyelocytic leukemia.
    Qin YZ; Huang XJ; Zhu HH
    Leukemia; 2018 Oct; 32(10):2285-2287. PubMed ID: 29568099
    [No Abstract]   [Full Text] [Related]  

  • 30. Tetraploidy acute promyelocytic leuemia with double t(15;17)/PML-RARA, a case report with review of literature.
    Dalia SM; Horna P; Zhang L
    Int J Clin Exp Pathol; 2014; 7(8):5363-8. PubMed ID: 25197424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute promyelocytic leukemia: new issues on pathogenesis and treatment response.
    Vitoux D; Nasr R; de The H
    Int J Biochem Cell Biol; 2007; 39(6):1063-70. PubMed ID: 17468032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical and laboratory features of patients with CD34(+) acute promyelocytic leukemia].
    Liang JY; Wu DP; Liu YJ; Ma QF; Xue YQ; Zhu MQ; Chen ZX
    Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):196-8. PubMed ID: 19615259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The t(15;17) translocation in acute promyelocytic leukemia.
    Lavau C; Dejean A
    Leukemia; 1994 Oct; 8(10):1615-21. PubMed ID: 7934155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PML/RARα-Regulated miR-181a/b Cluster Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia.
    Bräuer-Hartmann D; Hartmann JU; Wurm AA; Gerloff D; Katzerke C; Verga Falzacappa MV; Pelicci PG; Müller-Tidow C; Tenen DG; Niederwieser D; Behre G
    Cancer Res; 2015 Aug; 75(16):3411-24. PubMed ID: 26041820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Basic and clinical studies of the gene product-targeting therapy based on leukemogenesis--editorial].
    Chen SJ; Chen LJ; Zhou GB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):1-8. PubMed ID: 15748426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retinoid differentiation therapy in promyelocytic leukemia.
    Chomienne C; Fenaux P; Degos L
    FASEB J; 1996 Jul; 10(9):1025-30. PubMed ID: 8801163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel HNRNPC-RARA fusion in acute promyelocytic leukaemia lacking PML-RARA rearrangement, sensitive to venetoclax-based therapy.
    Liu M; Zhao X; Pan W; Qian Z; Du M; Wang LM; Huang H; Xiao H
    Br J Haematol; 2021 Oct; 195(2):e123-e128. PubMed ID: 34254314
    [No Abstract]   [Full Text] [Related]  

  • 38. Therapy-related myeloproliferative neoplasm with ETV6-PDGFRB rearrangement following treatment of acute promyelocytic leukemia.
    Malfuson JV; Konopacki J; Fagot T; Desangles F; Bories D; Souleau B; de Revel T
    Ann Hematol; 2011 Dec; 90(12):1477-9. PubMed ID: 21350831
    [No Abstract]   [Full Text] [Related]  

  • 39. Rapid detection of PML-RARA fusion gene by novel high-speed droplet-reverse transcriptase-polymerase chain reaction: possibility for molecular diagnosis without lagging behind the morphological analyses.
    Sueki A; Matsuda K; Taira C; Yamaguchi A; Koeda H; Takagi F; Kobayashi Y; Sugano M; Honda T
    Clin Chim Acta; 2013 Jan; 415():276-8. PubMed ID: 23159843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute promyelocytic leukemia with cryptic t(15;17) on isochromosome 17: a case report and review of literature.
    Tang Y; Wang Y; Hu L; Meng F; Xu D; Wan K; Huang L; Li C; Zhou J
    Int J Clin Exp Pathol; 2015; 8(11):15294-300. PubMed ID: 26823883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.